Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
Jill E. Bagalman, MSW
Advertisement
Articles by Jill E. Bagalman, MSW
Advertisement
Latest Updated Articles
- Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Published: January 16th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
3
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
4
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
5
